preview

Panic Disorders: A Case Study

Decent Essays

It is estimated that 1% to 5% of people will experience a Panic Disorder at some point in their life (Andrisano, Balzarro, Fabbri, Chiesa & Serretti, 2012). A Panic Disorder is a chronic and severe anxiety disorder that is defined by the presence of frequent panic attacks and persistent worrying about future panic attacks (Andrisano et al., 2012). Panic disorders have been known to cause impairment in both qualities of life and functioning (Andrisano et al., 2012). It is important to treat individuals that have panic disorders because studies have shown that people who suffer from panic disorders generally get worse over time if proper treatment interventions are not established (Andrisano et al., 2012). Treatments have been found to be effective …show more content…

These five classes are: SSRIs, SNRIs, Benzodiazepines, Tricyclic antidepressants and MAOIs (Monamine Oxidase Inhibitors) (Andrisano et al., 2012). The primary objectives of the study were to see which of these medications being used were considered first-line agents for treatment, and also to see if combining therapy (CBT) along with medication is more efficient in treatment than medication alone (Andrisano et al., 2012). After researchers conducted randomized trials results showed that SSRIs and SNRI venlafaxine are considered primary agents for patients with panic disorders (Andrisano et al., 2012). Both of these medications presented more tolerable side-effects and do a better job of reducing panic symptoms and anxiety levels (Andrisano et al., 2012). Results also showed that combining CBT and antidepressant medication together in treatment yielded better treatment results in 21 clinical trials and had a lower rate of relapse than with medication alone (Andriasano et al., …show more content…

It looked at data regarding first-line pharmacotherapy for treatment for patients with panic disorders (Batelaan, Van Balkom & Stein, 2012). After reviewing evidence-based pharmacotherapy for panic disorders, they concluded that SSRIs along with SNRIs venlafaxine and Benzodiazepines should be the primary medications for panic disorders (Batelaan et al., 2012). When analyzing the efficacy of these drugs, it showed that these medications stayed effective in both short-term and long-term treatment (Batelaan et al., 2012). The three aspects researchers looked at to determine the effectiveness of the drugs were side-effects, drop out rates and time of onset (Batelaan et al., 2012). When looking at the panic disorder clinical trials, drop out rates for SSRIs and Benzodiazepines were 18% and 15% respectively. TCAs and MAOIs on the other hand showed a 30% dropout rate among patients with panic disorders (Batelaan et al., 2012). When looking at onset of action, antidepressants (SSRIs and SNRIs venlafaxine) are relatively slow, however TCAs showed a slower onset than SSRIs, SNRIs venlafaxine and Benzodiazepines (Batelaan et al., 2012). Researchers concluded that both SSRIs and SNRIs venlafaxine should be considered as first-line agents for treatment along with Benzodiazepines. The study did mention however, that there have not been one to one comparisons between SSRIs and SNRIs

Get Access